Identification of a secondary RET mutation in a pediatric patient with relapsed acute myeloid leukemia leads to the diagnosis and treatment of asymptomatic metastatic medullary thyroid cancer in a parent: A case for sequencing the germline Journal Article


Authors: Pendrick, D. M.; Oberg, J. A.; Hsiao, S. J.; Chung, W. K.; Koval, C.; Sireci, A.; Kuo, J. H.; Satwani, P.; Glasser, C. L.; Sulis, M. L.; Mansukhani, M. M.; Glade Bender, J. L.
Article Title: Identification of a secondary RET mutation in a pediatric patient with relapsed acute myeloid leukemia leads to the diagnosis and treatment of asymptomatic metastatic medullary thyroid cancer in a parent: A case for sequencing the germline
Abstract: The incorporation of tumor-normal genomic testing into oncology can identify somatic mutations that inform therapeutic measures but also germline variants associated with unsuspected cancer predisposition. We describe a case in which a RET variant was identified in a 3-yr-old male with relapsed leukemia. Sanger sequencing revealed the patient's father and three siblings carried the same variant, associated with multiple endocrine neoplasia 2A (MEN2A). Evaluation of the father led to the diagnosis and treatment of metastatic medullary thyroid carcinoma. Detection of RET mutations in families with hereditary MTC allows for genetic risk stratification and disease surveillance to reduce morbidity and mortality. © 2019 Pendrick et al.; Published by Cold Spring Harbor Laboratory Press.
Keywords: acute myeloid leukemia; medullary thyroid carcinoma
Journal Title: Cold Spring Harbor Molecular Case Studies
Volume: 5
Issue: 2
ISSN: 2373-2873
Publisher: Cold Spring Harbor Laboratory Press  
Date Published: 2019-04-01
Start Page: a003889
Language: English
DOI: 10.1101/mcs.a003889
PUBMED: 30936199
PROVIDER: scopus
PMCID: PMC6549565
DOI/URL:
Notes: Article -- Export Date: 1 May 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors